Clinical Trials Directory

Trials / Completed

CompletedNCT02884440

Transverse Abdominis Plane Block for Anterior Approach Spine Surgery

Transverse Abdominis Plane Block for Anterior Approach Spine Surgery: A Prospective Randomized Study

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
43 (actual)
Sponsor
Rennes University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Therapeutic, prospective, randomized, double blind, placebo-controlled, in intention to treat, monocentric study to evaluate the analgesic efficacy of a bilateral TAP block after spine surgery with 24 hours morphine consumption

Detailed description

ALIF is a commonly performed procedure for the treatment of degenerative diseases of the lumbar spine or spondylolisthesis. This technique has many advantages attributed to the absence of posterior spinal muscular pain, a more direct visualization of the disk space, lower incidence of neurological injuries… However, patients experienced moderate to high post operative parietal abdominal pain due to this specific anterior approach. The systematic need for opioids administration may cause many complications and delay the post operative recovery time. The TAP block has been described as an effective pain control technique after various lower abdominal surgeries, reducing both pain scores and 24 hours opioids consumption. However the analgesic efficacy of this technique on specific parietal abdominal pain experienced after spine surgery by anterior approach is not clear

Conditions

Interventions

TypeNameDescription
DRUGTAP block ropivacaine
DRUGTAP block placebo
DRUGGeneral anesthesiaInduction PROPOFOL 10mg/ml REMIFENTANIL 50 μg/ml CISATRACURIUM 2mg/ml if necessary DEXAMETHASONE 8 mg KETAMINE 0,15mg/kg Maintenance PROPOFOL 10mg/ml REMIFENTANIL 50 μg/ml

Timeline

Start date
2016-11-07
Primary completion
2019-05-25
Completion
2019-05-25
First posted
2016-08-31
Last updated
2023-05-24

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02884440. Inclusion in this directory is not an endorsement.